Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prozac's home court advantage?

Executive Summary

Two of three possible outcomes of appeal in Barr fluoxetine patent challenge would be positive for Lilly, company tells July 20 call. Upholding patents would be positive, as would a remand for trial, because then "the patent case would go to a trial for the first time, here in Indianapolis at the U.S. Federal Court for the Southern District of Indiana, with the honorable Judge Sarah Evans Barker presiding," IR Director Patricia Martin said. While an appellate decision overturning Lilly's patents would obviously favor Barr, Lilly would have an appeal, Martin added
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS036439

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel